Intradermal rabies vaccine

Anthony Gherardin and Sonny Lau
Med J Aust 2007; 187 (1): . || doi: 10.5694/j.1326-5377.2007.tb01128.x
Published online: 2 July 2007

To the Editor: Rabies vaccine is recommended for pre-exposure prophylaxis in travellers over 1 year old who intend to travel to predominantly developing countries where canine rabies is endemic. The incidence of dog bites in such countries is relatively high, being more common among travellers than typhoid fever.1 Postexposure rabies treatment of pre-immunised travellers is simpler, cheaper and safer than treatment of those who have not been immunised.

  • The Travel Doctor (TMVC), Melbourne, VIC.


  • 1. Steffen R, Connor BA. Vaccines in travel health: from risk assessment to priorities. J Travel Med 2005; 12: 26-35.
  • 2. World Health Organization. International travel and health. Situation as on 1 January 2005. Geneva: WHO, 2005.
  • 3. National Health and Medical Research Council. Australian immunisation handbook. 8th ed. Canberra: NHMRC, 2003.
  • 4. Atanasiu P, Perrin P, Delagneau JF. Use of an enzyme immunoassay with protein A for rabies antigen and antibody determination. Dev Biol Stand 1980; 46: 207-215.
  • 5. Lau C, Sisson J. The effectiveness of intradermal pre-exposure rabies vaccination in an Australian travel medicine clinic. J Travel Med 2002; 9: 285-288.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.